Cargando…

Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study

PURPOSE: This multicenter, randomized, double-blind, placebo-controlled phase 2 study evaluated the efficacy and safety of TAC-302, a novel drug that restores neurite outgrowth, in patients with detrusor underactivity (DU) and overactive bladder (OAB). METHODS: After 2–4 weeks of observation, patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Masaki, Gotoh, Momokazu, Yokoyama, Osamu, Kakizaki, Hidehiro, Yamanishi, Tomonori, Yamaguchi, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617838/ https://www.ncbi.nlm.nih.gov/pubmed/36205739 http://dx.doi.org/10.1007/s00345-022-04163-4

Ejemplares similares

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
por: Jiang, Yuan-Hong, et al.
Publicado: (2023)

Cardiovascular safety of vibegron, a new β3‐adrenoceptor agonist, in older patients with overactive bladder: Post‐hoc analysis of a randomized, placebo‐controlled, double‐blind comparative phase 3 study
por: Yoshida, Masaki, et al.
Publicado: (2021)

Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study
por: Yoshida, Masaki, et al.
Publicado: (2020)

Efficacy of novel β(3)‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study
por: Yoshida, Masaki, et al.
Publicado: (2018)

Underactive Bladder and Detrusor Underactivity: New Advances and Prospectives
por: Wang, Jiaxin, et al.
Publicado: (2023)

Detrusor-Overactivity-Related Voiding in Women Mimics Bladder Outflow Obstruction and Conceals Underactivity
por: Kitta, Takeya, et al.
Publicado: (2023)

Coexistent Detrusor Overactivity-Underactivity in Patients with Pelvic Floor Disorders
por: Frigerio, Matteo, et al.
Publicado: (2022)

Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study)
por: Yamaguchi, Osamu, et al.
Publicado: (2018)

Detrusor underactivity: To tone or not to tone the bladder?
por: Krishnamoorthy, Sriram, et al.
Publicado: (2009)

Detrusor Underactivity in Men with Bladder Outlet Obstruction
por: Lee, Hsiang-Ying, et al.
Publicado: (2022)

Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
por: Kaga, Kanya, et al.
Publicado: (2020)

Therapeutic effect of adipose-derived regenerative cells on bladder function in rats with underactive bladder
por: Mori, Aya, et al.
Publicado: (2020)

Detrusor underactivity versus bladder outlet obstruction clinical and urodynamic factors
por: Kalil, Jefferson, et al.
Publicado: (2020)

Potential urine biomarkers in bladder outlet obstruction-related detrusor underactivity
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Defining Voiding Dysfunction in Women: Bladder Outflow Obstruction Versus Detrusor Underactivity
por: Mytilekas, Konstantinos-Vaios, et al.
Publicado: (2021)

Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study
por: Kakizaki, Hidehiro, et al.
Publicado: (2020)

Does uroflowmetry parameter facilitate discrimination between detrusor underactivity and bladder outlet obstruction?
por: Lee, Kwon Soo, et al.
Publicado: (2016)

Identifying occult bladder outlet obstruction in women with detrusor-underactivity-like urodynamic profiles
por: Chow, Po-Ming, et al.
Publicado: (2021)

Clinical Correlation of Bladder Electron Microscopic Characteristics in Patients with Detrusor Underactivity of Various Etiologies
por: Jhang, Jia-Fong, et al.
Publicado: (2022)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction
por: Yang, Tsai-Hwa, et al.
Publicado: (2018)

Detrusor Underactivity as an HCN-Mediated Failure of Resilience in Aging
por: Rosenberg, Dawn, et al.
Publicado: (2020)

Female detrusor underactivity: Two uterine leiomyoma cases
por: Shimizu, Ayami, et al.
Publicado: (2020)

Detrusor underactivity is associated with metabolic syndrome in aged primates
por: Biscola, Natalia P., et al.
Publicado: (2023)

Role of stem cell factor in the regulation of ICC proliferation and detrusor contraction in rats with an underactive bladder
por: Feng, Jianli, et al.
Publicado: (2017)

Pathogenesis evidence from human and animal models of detrusor underactivity
por: Jhang, Jia-Fong, et al.
Publicado: (2021)

Significance of a decrease in the proportion of detrusor muscle to bladder wall for non-invasive diagnosis of detrusor underactivity in men with lower urinary tract symptoms
por: Lee, Junghoon, et al.
Publicado: (2022)

Underactive bladder
por: Lee, Kyu-Sung
Publicado: (2017)

A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity
por: Sugimoto, Koichi, et al.
Publicado: (2015)

The challenges in the diagnosis of detrusor underactivity in clinical practice: A mini-review
por: Ahmed, Ahmed, et al.
Publicado: (2016)

Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction
por: Bellucci, Carlos H.S., et al.
Publicado: (2017)

Urinary ATP May Be a Dynamic Biomarker of Detrusor Overactivity in Women with Overactive Bladder Syndrome
por: Silva-Ramos, Miguel, et al.
Publicado: (2013)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Nitti, Victor, et al.
Publicado: (2023)

Pathophysiology of the underactive bladder
por: Aizawa, Naoki, et al.
Publicado: (2017)

Low-frequency electrotherapy for female patients with detrusor underactivity due to neuromuscular deficiency
por: Xu, Dan-Feng, et al.
Publicado: (2012)

Surgical treatment of detrusor underactivity: a short term proof of concept study
por: Blaivas, Jerry G., et al.
Publicado: (2017)

Herpes zoster-induced urologic and gastrointestinal dysfunction with residual neurogenic detrusor underactivity
por: Biglione, Bianca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4rptf0t5fspr7pl52d4hcr34dh